Jaya Sahni

Title: Jaya Sahni: Innovator in Anti-HIV Therapeutics

Introduction

Jaya Sahni is a prominent inventor based in Seattle, WA, who has made significant contributions to the field of immunology and gene therapy. Her innovative work focuses on developing methods to combat HIV through genetic modifications of T-cells. With a strong commitment to advancing medical science, she has secured a patent that showcases her expertise and dedication.

Latest Patents

Jaya Sahni holds a patent for "CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies." This patent relates to methods of genetically modifying T-cells to lack a co-receptor for HIV. The application outlines techniques for creating nucleic acids encoding chimeric antigen receptors and genetically modified T-cells that can be used to treat, inhibit, or ameliorate HIV in affected individuals.

Career Highlights

Jaya is currently affiliated with Seattle Children's Hospital, where she continues her research and development efforts. Her work is pivotal in the ongoing fight against HIV, and her innovative approaches have the potential to transform treatment methodologies.

Collaborations

Jaya collaborates with esteemed colleagues, including Thor Wagner and Andrew M Scharenberg, who contribute to her research initiatives and help advance her groundbreaking work.

Conclusion

Jaya Sahni's contributions to the field of anti-HIV therapeutics through her innovative patent and collaborative efforts highlight her as a key figure in medical research. Her work not only showcases her inventiveness but also holds promise for improving the lives of those affected by HIV.